| [Secondary stroke prevention - an update]. | |
| | |
MedLine Citation:
|
PMID: 20927689 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Organised secondary prevention is a prerequisite for successful stroke therapy. One of the most relevant factors is elevated blood pressure. It has been shown that long-term blood pressure treatment leads to a significant reduction in mortality of almost 10 % over a 5-year period. Additionally, a large meta-analysis in almost 1 million patients confirmed that blood pressure reduction leads to a constant reduction in secondary cerebrovascular events by 40 %, both in primary and secondary prevention. The preventive effect was stronger as the blood pressure reduction increased. Interactions between proton-pump inhibitors and the antiplatelet agent clopidogrel did not receive scientific confirmation. There is no reason to avoid this combination. Patients suffering from atrial fibrillation and stroke should, whenever possible, be treated by oral anticoagulation. In cases in which this treatment is abandoned, the combination of aspirin and clopidogrel offers some marginal benefits over aspirin alone (higher stroke risk reduction, but increase in brain haemorrhages). Dabigatran is a new direct oral thrombin antagonist. It has the advantage compared to the oral vitamin K antagonists that it acts immediately after intake and does not need further regular coagulation test controls. The huge RELY study revealed that dabigatran is safer with the same efficacy in the lower dose, but more effective with the same safety in the higher dose, compared to oral vitamin K antagonists. It will be licensed in 2010. Statins seem to be beneficial for as long as 10 years after a cerebrovascular accident. Carotid stenosis treatment seems to be better done by operation as revealed by the International Carotid Stenosis Stenting study. A patent foramen ovale is a slight risk factor with an OR of 1.1. Therefore, any aggressive treatment options in patients with stroke and pfo seem to be unjustified. |
| | |
Authors:
|
G F Hamann; J Röther |
Related Documents
:
|
21193469 - Dynamics of extravascular pulmonary water and intracranial pressure in patients with is... 17261979 - Preventive effects of green tea catechins on spontaneous stroke in rats. 11833629 - Effect of head positioning on intracranial blood flow velocities in acute ischemic stro... 8728859 - Cardiovascular measurements in animals in the milligram range. 1544289 - Hemodynamic effects of quinidine and famotidine in patients with congestive heart failure. 8201779 - Postprandial hemodynamic changes evaluated by a doppler echocardiographic method. 7635539 - Pulse pressure and resistance artery structure in the elderly. 1104889 - Hemodynamic alterations with positive end-expiratory pressure: the contribution of the ... 3628459 - Examination of diltiazem for preservation of myocardial function after brief regional i... |
Publication Detail:
|
Type: English Abstract; Journal Article; Review Date: 2010-10-06 |
Journal Detail:
|
Title: Fortschritte der Neurologie-Psychiatrie Volume: 78 ISSN: 1439-3522 ISO Abbreviation: Fortschr Neurol Psychiatr Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-10-07 Completed Date: 2011-01-21 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8103137 Medline TA: Fortschr Neurol Psychiatr Country: Germany |
Other Details:
|
Languages: ger Pagination: 572-81 Citation Subset: IM |
Copyright Information:
|
© Georg Thieme Verlag KG Stuttgart · New York. |
Affiliation:
|
Neurologische Klinik, Dr. Horst Schmidt Klinik GmbH, Wiesbaden. gerhard.hamann@hskwiesbaden.de |
Vernacular Title:
|
Schlaganfallprävention - ein Update. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anticoagulants
/
therapeutic use Antihypertensive Agents / therapeutic use Atherosclerosis / prevention & control Blood Pressure / physiology Carotid Stenosis / complications, therapy Combined Modality Therapy Diabetes Complications / therapy Humans Hypertension / complications, drug therapy Platelet Aggregation Inhibitors / therapeutic use Stents Stroke / etiology, prevention & control* Vitamins / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Anticoagulants; 0/Antihypertensive Agents; 0/Platelet Aggregation Inhibitors; 0/Vitamins |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: [Acute stroke treatment - an update].
Next Document: [Antiepileptic drug-induced encephalopathy].